January 4, 2018 / 5:24 PM / 5 months ago

BRIEF-Inventiva Announces Positive DSMB Review In Phase IIb Fasst Trial In Systemic Sclerosis With Lanifibranor

Jan 4 (Reuters) - INVENTIVA SA:

* REG-INVENTIVA : INVENTIVA ANNOUNCES POSITIVE DSMB REVIEW IN PHASE IIB FASST TRIAL IN SYSTEMIC SCLEROSIS WITH LANIFIBRANOR

* TOPLINE RESULTS ANTICIPATED EARLY 2019

* ‍STUDY IS PROGRESSING AS PLANNED WITH NO SPECIFIC CONCERNS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below